💊Otsuka’s JYNARQUE™ Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD) Wednesday April 25th, 2018By Tokio X'press FDA, Pharmaceutical otsuka
